Target intelligence / Profile preview

Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex (DLAT)

Target
DLAT
Molecular classification
Enzyme, Transferase, Mitochondrial protein
01

Overview

The Pyruvate dehydrogenase complex E2 subunit, also known as dihydrolipoyllysine-residue acetyltransferase (DLAT), is a core enzymatic component of the mitochondrial pyruvate dehydrogenase complex (PDC) (UniProt: P10515). It plays a vital role in aerobic respiration by catalyzing the conversion of pyruvate into acetyl-CoA, effectively linking glycolysis to the tricarboxylic acid (TCA) cycle (PubMed: 23543447). Structurally, the E2 subunit forms the scaffold of the complex and utilizes a lipoic acid cofactor to transfer acetyl groups between active sites. In clinical medicine, PDC-E2 is most recognized as the primary autoantigen in Primary Biliary Cholangitis (PBC), where anti-mitochondrial antibodies (AMA) target this protein, leading to the autoimmune destruction of small bile ducts (PubMed: 28803133). Beyond autoimmunity, DLAT is an emerging target in oncology, as certain cancer cells rely on PDC activity for metabolic flexibility. Drugs like devimistat (CPI-613) inhibit E2 to disrupt mitochondrial metabolism in tumor cells (ClinicalTrials.gov: NCT03504423). Genetic mutations in the DLAT gene can also lead to pyruvate dehydrogenase deficiency, a condition characterized by lactic acidosis and severe neurological dysfunction (NCBI Gene: 1737). Overall, the E2 subunit is a critical metabolic node with significant implications in autoimmune, genetic, and neoplastic diseases.

Other names
PDC-E2Dihydrolipoamide S-acetyltransferaseDLTAE2 component of pyruvate dehydrogenase complexM2 autoantigen
02

Mechanism of action

The E2 subunit catalyzes the transfer of an acetyl group from the lipoyl group of the enzyme to coenzyme A (CoA), producing acetyl-CoA and leaving a reduced dihydrolipoyl group (PubMed: 23543447). This reaction is part of the multi-step oxidative decarboxylation of pyruvate. Drugs like devimistat act by mimicking the lipoate cofactor, leading to the inhibition of the E2 and E3 subunits within the complex (ClinicalTrials.gov: NCT03504423).

03

Biological functions

Pyruvate decarboxylationAcetyl-CoA biosynthetic processTricarboxylic acid cycleMitochondrial energy metabolism
04

Disease associations

Primary biliary cholangitisPyruvate dehydrogenase deficiencyCancerCongenital lactic acidosis
05

Safety considerations

Lactic acidosisNeurological toxicityMetabolic decompensationInterference with central energy metabolism
06

Interacting drugs

Devimistat

1 more in the full profile.

07

Biomarkers

Anti-mitochondrial antibodies (AMA)Anti-M2 antibodySerum lactate levelsLactate-to-pyruvate ratio

Beyond the preview

Go deeper on Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex (DLAT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex (DLAT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call